NEW YORK (GenomeWeb) – Investment firm BTIG today upgraded Agilent Technologies' stock to a Buy rating on improving confidence in the company's outlook. 

Analyst Dane Leone upgraded Agilent from an earlier Neutral rating and set the 12-month price target on the firm's stock at $52. In a research note, he cited Agilent's China business, and said that after two years of having to deal issues in the region those operations are poised to improve.  

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.